Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Animal Health, Business Development & Division Support by Year
Animal Health, Business Development & Division Support R&D ($B, legacy disclosure)
Merck Animal Health, Business Development & Division Support: $4.10B in FY2022, down 12.8% from a year earlier. No newer figure appears in the documents we track.
Where the FY2022 figure comes from
“Also included in R&D expenses are Animal Health research costs, licensing costs and costs incurred by other divisions in support of R&D activities, including depreciation, production and general and administrative, which in the aggregate were $4.1 billion in 2022 and $4.7 billion”
Source: Form 10-K (mrk-20221231.htm, filed 2023-02-24) ↗
Reported in Form 10-K MD&A Research and Development.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Animal Health, Business Development & Division Support R&D ($B, legacy disclosure) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | 4.10 | -12.8% | Form 10-K (mrk-20221231.htm, filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 4.70 | +74.1% | Form 10-K (mrk-20221231.htm, filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 2.70 | +3.8% | Form 10-K (mrk-20201231.htm, filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 2.60 | +13.0% | Form 10-K (mrk-20201231.htm, filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 2.30 | – | Form 10-K (mrk1231201910k.htm, filed 2020-02-26) ↗ |
Cite this data
StockData. (2026). Merck Animal Health, Business Development & Division Support, annual FY2018–FY2022 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rd-ah-bd-support-b
See every metric in the Merck KPI table. Data updated Oct 26, 2026.